CELZ | Creative Medical Technology Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.16 - 3.43
52 Week Range	2.9001 - 10.28
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	6,473
Average Volume	7,185
Shares Outstanding	1,338,130
Market Cap	4,541,613
Sector	Healthcare
Industry	Biotechnology
IPO Date	2015-11-06

Valuation
Profitability
Growth
Health
P/E Ratio	-0.83
Forward P/E Ratio	N/A
EPS	-4.07
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	4
Country	USA
Website	CELZ

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

CELZ's peers: RGBP, THER, ENZC, SONN, ICU, VIRI, ZVSA, REVB, PALI, QNRX, VRAX, UNCY, ADXN, ACGN, ERYP, SNGX, ATXI, CDIO, PXMD

*Chart delayed

Analyzing fundamentals for CELZ we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see CELZ Fundamentals page.

Watching at CELZ technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CELZ Technicals page.